Cargando…

Proposal for the development of an international minimal data collection for juvenile dermatomyositis (JDM)

Detalles Bibliográficos
Autores principales:	McCann, Liza J, Pilkington, Clarissa, Beard, Laura, Ravelli, Angelo, Huber, Adam, Wedderburn, Lucy R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194710/ http://dx.doi.org/10.1186/1546-0096-9-S1-P51

Ejemplares similares

Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use
por: McCann, Liza J., et al.
Publicado: (2015)

Developing a provisional, international Minimal Dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research
por: McCann, Liza J, et al.
Publicado: (2014)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era
por: Smith, S, et al.
Publicado: (2008)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

Clinically inactive disease in juvenile dermatomyositis – a proposed revision to the printo criteria
por: Almeida, Beverley, et al.
Publicado: (2014)

Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM)
por: Avie, Y Butbul, et al.
Publicado: (2008)

Case of juvenile dermatomyositis (JDM), thrombotic thrombocytopenic purpura (TTP), and Purtscher retinopathy
por: Goldzweig, Ofra, et al.
Publicado: (2012)

JDM update September 2014
por: Pilkington, Clarissa
Publicado: (2014)

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile dermatomyositis
por: Enders, Felicitas Bellutti, et al.
Publicado: (2014)

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients
por: Ferrari, C, et al.
Publicado: (2008)

Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM)
por: Abdul-Aziz, Rabheh, et al.
Publicado: (2017)

Consensus-based recommendations for the management of juvenile dermatomyositis
por: Enders, Felicitas Bellutti, et al.
Publicado: (2017)

Tubuloreticular inclusions in juvenile dermatomyositis: a diagnostically useful marker?
por: Yasin, Shireena A, et al.
Publicado: (2014)

Comparison of the utility and validity of three scoring tools to detect skin disease in patients with juvenile dermatomyositis
por: Campanilho-Marques, Raquel, et al.
Publicado: (2014)

The Vasculopathy of Juvenile Dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2018)

Mapping the current psychology provision for children and young people with juvenile dermatomyositis
por: Livermore, Polly, et al.
Publicado: (2021)

Sub-phenotyping of juvenile dermatomyositis: can it assist clinical decisions?
por: Yasin, Shireena A, et al.
Publicado: (2014)

Currently recommended skin scores correlate highly in the assessment of patients with Juvenile Dermatomyositis (JDM)
por: Gebreamlak, Alexander, et al.
Publicado: (2023)

Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate
por: Ursu, S, et al.
Publicado: (2011)

Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research
por: McCann, Liza J, et al.
Publicado: (2018)

PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report
por: Varnier, GC, et al.
Publicado: (2013)

Comparison of data from the juvenile dermatomyositis national (UK & Ireland) cohort biomarker study and repository for idiopathic inflammatory myopathies with a survey of current practice throughout the UK and Ireland
por: Martin, N, et al.
Publicado: (2011)

Comparison of Children With Onset of Juvenile Dermatomyositis Symptoms Before or After Their Fifth Birthday in a UK and Ireland Juvenile Dermatomyositis Cohort Study
por: Martin, N, et al.
Publicado: (2012)

Effectiveness of anti-TNF-α agents in the treatment of refractory juvenile dermatomyositis
por: Boulter, EL, et al.
Publicado: (2011)

Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models
por: Deakin, Claire T, et al.
Publicado: (2020)

Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients
por: Campanilho-Marques, Raquel, et al.
Publicado: (2020)

Regulatory B cell Il-10 production is diminished in juvenile dermatomyositis
por: Piper, Christopher, et al.
Publicado: (2014)

The PRINTO provisional definition of remission in juvenile dermatomyositis
por: Lazarevic, D, et al.
Publicado: (2011)

A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies
por: Martin, Neil, et al.
Publicado: (2011)

Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling
por: Deakin, Claire T., et al.
Publicado: (2018)

PReS-FINAL-2130-A: Effectiveness of intravenous cyclophosphamide in severe or refractory juvenile dermatomyositis - a national cohort study UK and Ireland
por: Moraitis, E, et al.
Publicado: (2013)

OA05 Clinical presentation, risk factors and prognosis of MDA5-positive JDM; clinical diversity and red flags
por: McLellan, Kirsty, et al.
Publicado: (2022)

How do tissue infiltrating B cells and plasma cells correlate with other inflammatory features in muscle tissue from patients with JDM?
por: Sag, Erdal, et al.
Publicado: (2014)

Juvenile Dermatomyositis (JDM) Complicated by Thrombotic Thrombocytopenic Purpura (TTP) and Purtscher's Retinopathy Responsive to Rituximab: Case Report and Literature Review
por: Gullapalli, Keerthi, et al.
Publicado: (2020)

Juvenile Dermatomyositis: what comes next? Long-term outcomes in childhood myositis from a patient perspective
por: Boros, C., et al.
Publicado: (2022)

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
por: Ll Wilkinson, Meredyth G., et al.
Publicado: (2021)

Myeloid cells which secrete S100 proteins in juvenile dermatomyositis may contribute to disease activity
por: Varsani, H, et al.
Publicado: (2008)

Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America
por: Trail, L, et al.
Publicado: (2008)

OA29 Blotting-based assays under-detected TIF1-gamma and NXP2 autoantibodies compared to immunoprecipitation in Juvenile Dermatomyositis cohorts
por: Nguyen, Huong D, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_73qajk58ae8tvbq33ijphl4a76